Osphos is a solution for injection designed specifically for horses, targeting the alleviation of clinical forelimb lameness associated with bone resorptive processes, particularly affecting the distal sesamoid, commonly known as the navicular bone. This condition, prevalent in adult horses, can significantly impair their mobility and performance.

The active ingredient in Osphos is clodronic acid, present in a concentration of 51mg/ml. Clodronic acid is a bisphosphonate that acts by inhibiting bone resorption, thereby helping to preserve bone density and integrity. By targeting the underlying cause of forelimb lameness, Osphos aims to provide relief and improve the overall comfort and soundness of affected horses.

The 15ml vial packaging ensures convenient administration of the solution for injection. Osphos offers a valuable therapeutic option for veterinarians and horse owners seeking effective management of navicular syndrome-related lameness in adult horses.

No items found.